Understanding the impact of CFTR modulators on CF airway microbiology and the effects of these new drugs on chronic and acute airway infections, as well as evaluating their effects in combination with antibiotics, will extend our current understanding of the mechanisms of airway infection and will play an essential role in developing and improving strategies for managing airway infections in CF. This evidence concerns the gene CFTR and cystic fibrosis.